QS Investors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-4,745
Closed -$381K 2079
2016
Q4
$381K Hold
4,745
﹤0.01% 965
2016
Q3
$378K Buy
4,745
+800
+20% +$64.6K ﹤0.01% 954
2016
Q2
$308K Sell
3,945
-294
-7% -$21K ﹤0.01% 1018
2016
Q1
$233K Sell
4,239
-387
-8% -$21.1K ﹤0.01% 1050
2015
Q4
$286K Buy
4,626
+23
+0.5% +$1.45K ﹤0.01% 1020
2015
Q3
$290K Hold
4,603
﹤0.01% 996
2015
Q2
$336K Sell
4,603
-766
-14% -$55.3K ﹤0.01% 959
2015
Q1
$351K Hold
5,369
﹤0.01% 953
2014
Q4
$350K Sell
5,369
-3,500
-39% -$225K ﹤0.01% 916
2014
Q3
$533K Sell
8,869
-1,100
-11% -$71.9K 0.01% 439
2014
Q2
$690K Buy
9,969
+1,803
+22% +$117K 0.02% 431
2014
Q1
$534K Buy
8,166
+300
+4% +$19.5K 0.02% 447
2013
Q4
$488K Sell
7,866
-1,100
-12% -$63.7K 0.02% 430
2013
Q3
$481K Sell
8,966
-1,034
-10% -$53.3K 0.02% 428
2013
Q2
$461K Buy
+10,000
New +$433K 0.02% 535

Other funds holding STJ

QS Investors's STJ Position: Q1 2017 in Review

QS Investors sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,745 shares — an estimated $381K sold.

QS Investors first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $690K in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • QS Investors reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • QS Investors sold 4,745 St Jude Medical shares in Q1 2017, an estimated $381K.
  • QS Investors first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • QS Investors's St Jude Medical position peaked at $690K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on QS Investors's 13F filing for Q1 2017, filed 15 May 2017.